From histological and molecular pathology to the inclusion of antibody-drug conjugates in clinical practice against ovarian cancers: Mechanisms of action and pharmacological safety. - Barbosa SLM; Porto JCS; Pereira JC; Filho JIAB; da Silva FCC; de Castro E Sousa JM; de Oliveira Ferreira JR; Militão GCG; Ferreira PMP (Journal of toxicology and environmental health. Part B, Critical reviews, 2026)